Public disclosure of clinical research

The Lancet

Volumn 373, Issue 9672, 2009, Pages 1319-1320

  Strahlman, Ellen ^a   Rockhold, Frank ^a   Freeman, Andrew ^b  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; HEALTH CARE PERSONNEL; MEDICAL RESEARCH; PRIORITY JOURNAL; SCIENTIFIC LITERATURE;

EID: 64349124717     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60613-9     Document Type: Note

References (6)

1. Turner E.H., Matthews A.M., Linardatos E., et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358 (2008) 252-260
2. Easterbrook P.J., Berlin J.A., Goplan R., and Matthews D.R. Publication bias in clinical research. Lancet 337 (1991) 867-872
3. Rising K., Bacchetti P., and Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 5 (2008) 1561-1570
4. De Angelis C.D., Drazen J.M., Frizelle F.A., et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Lancet 365 (2005) 1827-1829
5. Zarin A., and Tse T. Moving toward transparency of clinical trials. Science 319 (2008) 1340-1342
6. GlaxoSmithKline. Clinical study register. http://www.gsk-clinicalstudyregister.com (accessed March 16, 2009).